Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism

Autor: Francisco José Borrego Utiel, Juan Antonio Bravo Soto, María José Merino Pérez, Isabel González Carmelo, Verónica López Jiménez, Teresa García Álvarez, Yelenei Acosta Martínez, María Auxiliadora Mazuecos Blanca

Publikováno v: Nefrología (English Edition), Vol 35, Iss 4, Pp 363-373 (2015)

Introduction: Secondary hyperparathyroidism is highly prevalent in kidney transplant recipients, and commonly results in hypercalcaemia; an association to osteopenia and bone fractures has also been observed. Paricalcitol has proved effective to cont

Externí odkaz: https://doaj.org/article/847b96fbf89441dcb1e5d97974003c7a

Necrotizing herpetic retinopathy in kidney-transplanted patients on mycophenolate mofetil

Autor: Manuel Morión Grande, M. Adoración Martín-Gómez, Aurora Quereda Castañeda, Verónica López Jiménez, Teresa Cabezas Fernández

Publikováno v: Nefrología (English Edition), Vol 36, Iss 5, Pp 575-577 (2016)

Externí odkaz: https://doaj.org/article/af3e2f54a1944c809b27e2b131b7afad

Efficacy and Safety of Eculizumab in Kidney Transplant Patients With Primary Atypical Hemolytic-Uremic Syndrome

Autor: Cristina Casas, González, Verónica, López-Jiménez, Teresa, Vázquez-Sánchez, Elena, Vázquez-Sánchez, Mercedes, Cabello, Domingo, Hernández-Marrero

Publikováno v: Transplantation Proceedings. 54:25-26

The atypical hemolytic-uremic syndrome (aHUS) is characterized by the triad of non-immune hemolytic anemia, thrombocytopenia, and acute renal failure. The aHUS is related to complement dysregulation; since the approval of eculizumab for this entity (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d99cb7dfcb5c8e5b53cfa2602757ad
https://doi.org/10.1016/j.transproceed.2021.09.063

Efecto de paricalcitol sobre el metabolismo mineralóseo en pacientes trasplantados renales con hiperparatiroidismo secundario

Autor: Verónica López Jiménez, María Auxiliadora Mazuecos Blanca, Juan Antonio Bravo Soto, María José Merino Pérez, Teresa García Álvarez, Francisco José Borrego Utiel, Isabel González Carmelo, Yelenei Acosta Martínez

Publikováno v: Nefrología, Vol 35, Iss 4, Pp 363-373 (2015)
Nefrología (Madrid) v.35 n.4 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

ResumenIntroducciónEl hiperparatiroidismo secundario es muy prevalente en pacientes trasplantados renales. Cursa con frecuencia con hipercalcemia y se ha asociado al desarrollo de osteopenia y fracturas óseas. El paricalcitol ha mostrado su eficaci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d660e8d7cd599126ef66df5a8a5a57ea
https://doi.org/10.1016/j.nefro.2015.06.018

Cinacalcet in the management of normocalcaemic secondary hyperparathyroidism after kidney transplantation: one-year follow-up multicentre study

Autor: Josep V, Torregrosa, Enrique, Morales, Juan M, Díaz, Josep, Crespo, Juan, Bravo, Gonzalo, Gómez, Miguel A, Gentil, Alberto, Rodríguez-Benot, Minerva, Rodríguez-García, Verónica, López-Jiménez, Álex, Gutiérrez-Dalmau, Luisa, Jimeno, M José, Pérez-Sáez, Rafael, Romero, Carlos, Gómez-Alamillo, Raphael, Pereira Paschoalin

Background: The effect of cinacalcet in patients with persistent secondary hyperparathyroidism (SHPT) after kidney transplantation (KT) has mainly been reported in patients with secondary hypercalcaemia. Objectives: Our objective was to assess the lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3fc3c1c8f765502faa1710817c3fd8b7
https://doi.org/10.3265/nefrologia.pre2013.aug.12183